Actively Recruiting
Austrian Hypertrophic Cardiomyopathy Registry
Led by Medical University of Graz · Updated on 2025-12-05
1000
Participants Needed
15
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting the Austrian Hypertrophic Cardiomyopathy (HCM) Registry, a prospective study enrolling patients from multiple outpatient clinics across Austria, including academic and non-academic centers. The registry aims to collect detailed clinical data on patients with HCM to facilitate innovative epidemiological analyses and improve standards of care by understanding gaps in evidence for this heart condition. Participants undergo a structured examination process that includes assessment of HCM symptoms, medical and family history, medication use, and specific red flags related to HCM. Clinical data collected include electrocardiograms, echocardiography, laboratory tests, and genetic testing. All information is entered into an electronic case report form to support multicenter analyses approved by a steering committee. During the study, patients will be followed over an average of 20 years with ongoing collection of data related to all-cause mortality and cardiovascular events. The registry supports cross-sectional and longitudinal analyses, aiming to harmonize clinical care for HCM patients in Austria. The total participation time depends on continued follow-up and data collection throughout the study duration.
CONDITIONS
Brief Title
Austrian Hypertrophic Cardiomyopathy Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients admitted to the HCM outpatient clinic of participating centers of the HCM Registry
- Interventricular septal thickness 3 mm and cardiomyopathy-specific red flags OR Interventricular septal thickness 5 mm not explainable by loading conditions OR Interventricular septal thickness 7 mm
- Willingness and ability to provide signed informed consent form (ICF) prior to participation in any study-related procedures
You will not qualify if you...
- Age < 18 years
- Known cardiac amyloidosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 20 years
Participants undergo structured clinical assessments including evaluation of symptoms, medical history, family history, and collection of clinical data such as electrocardiogram, echocardiography, laboratory tests, and genetic testing.
Visits occur at outpatient clinics across Austria, frequency depending on clinical care and study protocol
Trial Site Locations
Total: 15 locations
1
Kepler University Hospital Linz
Linz, Linz, Austria, 4021
Actively Recruiting
2
University Hospital St. Pölten
Sankt Pölten, Lower Austria, Austria, 3100
Actively Recruiting
3
Hospital Landesklinikum Wiener Neustadt
Wiener Neustadt, Lower Austria, Austria, 2700
Actively Recruiting
4
Paracelsus Medical University of Salzburg
Salzburg, State of Salzburg, Austria, 5020
Actively Recruiting
5
Clinic Cardinal Schwarzenberg
Schwarzach im Pongau, State of Salzburg, Austria, 5620
Actively Recruiting
6
Medical University of Vienna
Vienna, State of Vienna, Austria, 1090
Actively Recruiting
7
Favoriten Clinic Vienna
Vienna, State of Vienna, Austria, 1100
Active, Not Recruiting
8
Klinik Ottakring
Vienna, State of Vienna, Austria
Actively Recruiting
9
Hospital Graz 2 West
Graz, Styria, Austria, 8020
Actively Recruiting
10
Medical University of Graz
Graz, Styria, Austria, 8036
Actively Recruiting
11
Medical University of Innsbruck
Innsbruck, Tyrol, Austria, 6020
Actively Recruiting
12
Hospital St. Josef Braunau
Braunau am Inn, Upper Austria, Austria, 5280
Actively Recruiting
13
Ordensklinikum Linz
Linz, Upper Austria, Austria, 4020
Actively Recruiting
14
General Hospital St. Johann in Tirol
Sankt Johann in Tirol, Austria, 6380
Actively Recruiting
15
Clinic Wels-Grieskirchen
Wels-Grieskirchen, Austria, 4600
Actively Recruiting
Research Team
N
Nicolas D Verheyen, MD
V
Viktoria Santner, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here